NCT07197736View on ClinicalTrials.gov

DELINEATE-Prospective

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

October 1, 2027

Study Completion Date

October 1, 2028

Conditions
Valve Disease, AorticMitral Regurgitation (MR)Aortic StenosisValvular Heart DiseaseTricuspid Regurgitation (TR)Aortic Regurgitation
Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

Columbia University

OTHER

NCT07197736 - DELINEATE-Prospective | Biotech Hunter | Biotech Hunter